Antibacterial Principles From The Bark of Terminalia Arjuna: Scientific Correspondence
Antibacterial Principles From The Bark of Terminalia Arjuna: Scientific Correspondence
Antibacterial Principles From The Bark of Terminalia Arjuna: Scientific Correspondence
fluenced by an underlying bias in dinucleotide usage, for example, genes located in GC-rich regions of the chromosome preferentially utilize GC ending codons. It is important for heterologous gene expression to encode proteins with sequences that yield optimal expression. A good thumb rule for finding such an optimal sequence is to choose codons that are most frequent in highly expressed genes. The CAI provides an explicit way of finding such codons; the most frequent codons simply have highest relative adaptiveness values, and sequences with higher CAIs are preferred over those with lower CAIs. The study gives comprehensive information regarding the CAI and GC content of RNA genome plant viruses, and its influence on amino acid content.
2. Lobry, J. R. and Sueoka, N., Genome Biol., 2002, 3, 58. 3. Chen, S. L., Lee, W., Hottes, A. K., Shapiro, L. and McAdams, H. H., Proc. Natl. Acad. Sci. USA, 2004, 101, 3480 3485. 4. Vartanian, J. P., Henry, M. and WeinHobson, S., J. Gen. Virol., 2002, 83, 801805. 5. Aota, S. and Ikemura, T., Nucleic Acids Res., 1986, 14, 63456355. 6. Francino, M. P. and Ochman, H., Nature, 1999, 400, 3031. 7. Kanaya, S., Yamada, Y., Kinouchi, M., Kudo, Y. and Ikemura, T., J. Mol. Evol., 2001, 53, 290298. 8. Haas, J., Park, E. C. and Seed, B., Curr. Biol., 1996, 6, 315324. 9. Jansen, R., Bussemaker, H. J. and Gerstein, M., Nucleic Acids Res., 2003, 31, 22422251. 10. Mooers, A. O. and Holmes, E. C., Trends Ecol. Evol., 2000, 15, 365369. 11. Wolfe, K., Sharp, P. M. and Li, W. H., Nature, 1989, 337, 283285. 12. Sharp, P. M. and Li, W. H., Nucleic Acids Res., 1987, 15, 12811295. 13. Drake, J. W. and Holland, J. J., Proc. Natl. Acad. Sci. USA, 1999, 96, 13910 13913.
U. S. KADAM1,2,* S. B. GHOSH1
1
1. Sharp, P. M., Stenico, M., Peden, J. F. and Lyod, A. T., Biochem. Soc. Trans., 1993, 21, 835841.
Nuclear Agriculture and Biotechnology Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400 085, India 2 Present address: Department of Biotechnology, National Research Centre for Grapes, P.B. No. 03, Manjri Farm P.O., Solapur Road, Pune 412 307, India *For correspondence. e-mail: [email protected]
SCIENTIFIC CORRESPONDENCE
The bacterial sensitivity testing was done on the MuellerHinton (Hi-Media) agar No. 2. All the bacterial strains were grown on nutrient agar/broth for routine cultivation. Streptococcus mutans was grown on brainheart infusion agar at 28C. Tetracycline was used as control antibiotic in the bioactivity assays with bacteria. The test compounds were dissolved in DMSO and stored at 4C until use. Preliminary antibacterial activity testing was done according to Bauer et al.8. All bacteria were sub-cultured from 80C stock cultures into 5 ml of Mueller Hinton broth and incubated for 24 h at the desired temperature. For use as an inoculum, the turbidity of the bacterial suspension was adjusted to the McFarland standard 0.5 (ca. 1.5 108 cfu/ml). About 100 l of bacterial culture was spreadplated on solid medium and discs (5 mm diameter) containing test compound were placed on the pre-inoculated agar surface. Observations were recorded after 48 h of incubation of plates at the desired temperature. Twofold serial dilution technique was employed to assess the minimum inhibitory concentration (MIC) of a given compound using 96-well microplate. Optical density of the cultures was measured using Spectra Max 190 microplate reader (Molecular Devices Corp. USA). MIC was taken as the lowest concentration of the test compound which inhibited the appearance of visible growth. Bioassays indicated that all the extracts except the hexane fraction possessed significant activity against Gram-positive bacteria such as Staphylococcus aureus (MTCC 96), Staphylococcus epidermidis (MTCC 435), Streptococcus mutans (MTCC 890), Bacillus subtilis (MTCC 121) and Mycobacterium smegmatis MC2 155 (provided by Dr Anil K. Tyagi, UDSC). S. mutans and S. epidermidis were particularly highly sensitive to all the extracts. The initial crude bark extract also exhibited activity against Klebsiella pneumoniae (MTCC 109) and Enterococcus faecalis (MTCC 439), which however could not be detected in any of the solvent fractions. In general, the crude extract and the solvent fractions were inactive against Gram-negative bacteria. The water-insoluble substances have to be absorbed through the rather thick impermeable lipopolysaccharide layer, which presents a physical barrier in Gramnegative bacteria. Hence, the inactivity of extracts against Gram-bacteria is understandable. Thus, only small terpenoids which are able to form hydrogen bonds and therefore significantly interact with water, may be better able to traverse these pathways9. The diethyl ether fraction was further taken up for bioactivity-guided fractionation using silica gel column chromatography. Three pure tri-terpenoid compounds, viz. arjunic acid, arjungenin, arjunetin (a glycoside derivative of arjunic acid), the structures of which were confirmed by spectral analysis (Figure 1), were isolated. Arjunic acid and its glycosilated derivative showed moderate activity against S. epidermidis with MIC of 125 g/ml (Table 1). The glycosylation of arjunic acid increased its activity twofold against S. epidermidis. Growth of this bacterium in the presence of arjunetin and arjunic acid at twofold lower concentration than that of the MIC (i.e. 62.5 and 125 g/ml) indicated that there was no reduction in the initial titre even after 8 h (Figure 2). Hence the compounds could be bacteriostatic in nature. These findings indicate the presence of antibacterial principles in the bark of T. arjuna with arjunetin particularly showing selectively higher activity against S. epidermidis. Further derivatization of this molecule through structureactivity relationship studies
Table 1.
Minimal inhibitory concentration of tri-terpenoid compounds isolated from diethyl ether fraction of Terminalia arjuna extract Minimal inhibitory concentration (g/ml) Sreptococcus mutans 250 500 >500 Staphylococcus epidermidis 250 500 125 S. aureus >1000 >1000 >500 Pseudomonas aeruginosa >1000 >1000 >500
Figure 1. Chemical structure of triterpenes isolated from the bark of Terminalia arjuna: arjunic acid (1), arjungenin (2) and arjunetin (3).
Figure 2. 28
SCIENTIFIC CORRESPONDENCE
may lead to development of new antibiotic(s) of high potency.
1. Kumar, D. S. and Prabhakar, Y. S., J. Ethanopharmacol., 1987, 20, 173190. 2. Row, L. R., Murty, P. S., Subba Rao, G. S. R., Sastry, C. S. P. and Rao, K. V. J., Indian J. Chem., 1970, 8, 716721. 3. Honda, T., Murae, T., Tsuyuki, T., Takahashi, T. and Sawai, M., Bull. Chem. Soc. Jpn., 1976, 49, 32133218. 4. Anjaneyulu, A. S. R. and Rama Prasad, A. V., Phytochemistry, 1982, 21, 20572060. 5. Honda, T., Murae, T., Tsuyuki, T. and Takahashi, T., Chem. Pharm. Bull., 1976, 24, 178180. 6. Anjaneyulu, A. S. R. and Rama Prasad, A. V., Indian J. Chem. B, 1982, 21, 530533. 7. Tsuyuki, T., Hamada, Y., Honda, T., Takahashi, T. and Matsushita, K., Bull. Chem. Soc. Jpn., 1979, 52, 31273128. 8. Bauer, A. W., Kirby, W. M. M., Sherries, J. C. and Turck, M., Am. J. Clin. Pathol., 1966, 45, 493496. 9. Griffin, S. G., Wyllie, S. G., Markham, J. L. and Leach, D. N., Flavour Fragrance J., 1999, 14, 322332. ACKNOWLEDGEMENT. Financial assistance from DBT, India is acknowledged. Received 6 April 2006; revised accepted 10 October 2007
Analytical Chemistry Division, and Genetic Resources & Biotechnology Division, Central Institute of Medicinal and Aromatic Plants, Lucknow 226 015, India *For correspondence. e-mail: [email protected]